The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
CA Stock MarketDetailed Quotes
MDP Medexus Pharmaceuticals Inc
- 2.820
- +0.220+8.46%
15min DelayMarket Closed Dec 20 16:00 ET
69.52MMarket Cap23.11P/E (TTM)
2.820High2.610Low5.85KVolume2.650Open2.600Pre Close15.55KTurnover3.27052wk High0.03%Turnover Ratio24.65MShares1.47052wk Low0.122EPS TTM62.82MFloat Cap11.250Historical HighLossP/E (Static)22.27MShs Float0.880Historical Low-0.014EPS LYR8.08%Amplitude--Dividend TTM1.48P/B1Lot Size--Div YieldTTM
Medexus Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.27%26.3M | -13.54%27.28M | 4.59%113.05M | -9.33%25.96M | -12.25%25.21M | 9.54%30.33M | 36.92%31.56M | 40.93%108.1M | 41.31%28.63M | 35.08%28.73M |
| Operating revenue | -13.27%26.3M | -13.54%27.28M | 4.59%113.05M | -9.33%25.96M | -12.25%25.21M | 9.54%30.33M | 36.92%31.56M | 40.93%108.1M | 41.31%28.63M | 35.08%28.73M |
| Cost of revenue | -13.32%12.18M | -13.05%12.45M | 11.41%53.54M | -7.04%12.66M | -2.19%12.52M | 21.71%14.05M | 41.72%14.32M | 23.94%48.06M | 34.16%13.62M | 31.01%12.8M |
| Gross profit | -13.22%14.13M | -13.94%14.84M | -0.87%59.51M | -11.40%13.31M | -20.34%12.69M | 0.83%16.28M | 33.17%17.24M | 58.30%60.04M | 48.48%15.02M | 38.54%15.93M |
| Operating expense | -21.20%10.03M | -15.27%10.51M | -9.35%46.73M | -14.03%10.48M | -12.13%11.13M | -7.90%12.72M | -3.76%12.4M | 2.48%51.55M | 12.71%12.19M | 7.23%12.66M |
| Selling and administrative expenses | -22.64%7.96M | -16.24%8.7M | -8.84%38.44M | -12.27%8.64M | -11.95%9.12M | -8.67%10.29M | -2.85%10.39M | 9.24%42.16M | 20.84%9.85M | 10.41%10.35M |
| -Selling and marketing expense | -44.64%1.61M | -28.94%2.09M | -7.13%10.58M | -19.97%2.12M | 1.52%2.61M | -3.74%2.91M | -6.62%2.93M | 19.78%11.39M | 50.28%2.65M | 25.48%2.57M |
| -General and administrative expense | -13.95%6.35M | -11.24%6.62M | -9.47%27.86M | -9.43%6.52M | -16.40%6.51M | -10.48%7.37M | -1.28%7.46M | 5.80%30.77M | 12.70%7.2M | 6.20%7.78M |
| Research and development costs | -14.96%2.01M | -10.62%1.74M | -10.99%8.04M | -21.73%1.78M | -12.17%1.95M | -3.63%2.37M | -6.75%1.95M | -20.13%9.03M | -11.78%2.27M | -5.09%2.22M |
| Depreciation amortization depletion | -20.83%57K | 1.72%59K | -28.90%251K | -11.76%60K | -32.22%61K | -26.53%72K | -40.21%58K | -11.31%353K | -23.60%68K | -3.23%90K |
| -Depreciation and amortization | -20.83%57K | 1.72%59K | -28.90%251K | -11.76%60K | -32.22%61K | -26.53%72K | -40.21%58K | -11.31%353K | -23.60%68K | -3.23%90K |
| Operating profit | 15.36%4.1M | -10.54%4.33M | 50.63%12.79M | -0.07%2.83M | -52.08%1.57M | 52.60%3.55M | 7,834.43%4.84M | 168.59%8.49M | 503.28%2.83M | 1,169.28%3.27M |
| Net non-operating interest income (expenses) | 48.85%-2.16M | 52.27%-2.03M | 1.78%-13.36M | 38.43%-2.22M | 25.23%-2.66M | -28.42%-4.23M | -35.12%-4.26M | -11.31%-13.61M | -16.25%-3.61M | -12.41%-3.55M |
| Non-operating interest expense | -48.85%2.16M | -52.27%2.03M | -1.78%13.36M | -38.43%2.22M | -25.23%2.66M | 28.42%4.23M | 35.12%4.26M | 11.31%13.61M | 16.25%3.61M | 12.41%3.55M |
| Other net income (expenses) | -744.97%-2.52M | -233.44%-399K | 798.68%683K | -51.19%389K | 143.09%293K | 81.10%-298K | -80.53%299K | -99.63%76K | 300.50%797K | -130.60%-680K |
| Gain on sale of security | 81.54%-55K | -114.38%-43K | -109.83%-83K | -148.15%-377K | 195.13%293K | 75.06%-298K | -80.88%299K | -95.97%844K | 272.47%783K | -113.66%-308K |
| Special income (charges) | ---2.46M | ---356K | 199.74%766K | 5,371.43%766K | --0 | --0 | --0 | -368.29%-768K | -97.86%14K | -1,027.27%-372K |
| -Less:Restructuring and mergern&acquisition | --0 | --356K | -315.36%-1.65M | -11,714.29%-1.65M | --0 | --0 | --0 | 148.42%768K | 99.42%-14K | 1,027.27%372K |
| -Less:Impairment of capital assets | --2.46M | ---- | --888K | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
| Income before tax | 40.29%-581K | 114.93%1.9M | 102.10%106K | 8,150.00%990K | 17.19%-795K | 61.71%-973K | 156.96%884K | -31.96%-5.04M | 100.33%12K | 22.83%-960K |
| Income tax | -675.83%-691K | -124.46%-57K | 105.11%320K | 103.33%228K | -147.71%-261K | -36.51%120K | 251.30%233K | -565.46%-6.26M | -507.87%-6.84M | 681.91%547K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 110.06%110K | 200.61%1.96M | -117.53%-214K | -88.89%762K | 64.57%-534K | 59.96%-1.09M | 146.57%651K | 142.41%1.22M | 229.68%6.86M | -31.04%-1.51M |
| Net income continuous operations | 110.06%110K | 200.61%1.96M | -117.53%-214K | -88.89%762K | 64.57%-534K | 59.96%-1.09M | 146.57%651K | 142.41%1.22M | 229.68%6.86M | -31.04%-1.51M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 110.06%110K | 200.61%1.96M | -117.53%-214K | -88.89%762K | 64.57%-534K | 59.96%-1.09M | 146.57%651K | 142.41%1.22M | 229.68%6.86M | -31.04%-1.51M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 110.06%110K | 200.61%1.96M | -117.53%-214K | -88.89%762K | 64.57%-534K | 59.96%-1.09M | 146.57%651K | 142.41%1.22M | 229.68%6.86M | -31.04%-1.51M |
| Diluted earnings per share | 108.96%0.0045 | 166.67%0.08 | -116.67%-0.01 | -88.24%0.04 | 71.43%-0.02 | 64.29%-0.05 | 142.86%0.03 | 140.00%0.06 | 225.93%0.34 | 0.00%-0.07 |
| Basic earnings per share | 108.96%0.0045 | 166.67%0.08 | -116.67%-0.01 | -88.24%0.04 | 71.43%-0.02 | 64.29%-0.05 | 142.86%0.03 | 140.00%0.06 | 225.93%0.34 | 0.00%-0.07 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending CA Stocks
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.